147 related articles for article (PubMed ID: 10084634)
1. Paroxetine in the treatment of primary insomnia: preliminary clinical and electroencephalogram sleep data.
Nowell PD; Reynolds CF; Buysse DJ; Dew MA; Kupfer DJ
J Clin Psychiatry; 1999 Feb; 60(2):89-95. PubMed ID: 10084634
[TBL] [Abstract][Full Text] [Related]
2. Effect and safety of paroxetine combined with zolpidem in treatment of primary insomnia.
Yu ZH; Xu XH; Wang SD; Song MF; Liu Y; Yin Y; Mao HJ; Tang GZ
Sleep Breath; 2017 Mar; 21(1):191-195. PubMed ID: 28101753
[TBL] [Abstract][Full Text] [Related]
3. Doxepin in the treatment of primary insomnia: a placebo-controlled, double-blind, polysomnographic study.
Hajak G; Rodenbeck A; Voderholzer U; Riemann D; Cohrs S; Hohagen F; Berger M; Rüther E
J Clin Psychiatry; 2001 Jun; 62(6):453-63. PubMed ID: 11465523
[TBL] [Abstract][Full Text] [Related]
4. Tiagabine for the treatment of generalized anxiety disorder: a randomized, open-label, clinical trial with paroxetine as a positive control.
Rosenthal M
J Clin Psychiatry; 2003 Oct; 64(10):1245-9. PubMed ID: 14658975
[TBL] [Abstract][Full Text] [Related]
5. Paroxetine treatment of primary insomnia in older adults.
Reynolds CF; Buysse DJ; Miller MD; Pollock BG; Hall M; Mazumdar S
Am J Geriatr Psychiatry; 2006 Sep; 14(9):803-7. PubMed ID: 16943177
[TBL] [Abstract][Full Text] [Related]
6. Nefazodone in primary insomnia: an open pilot study.
Wiegand MH; Galanakis P; Schreiner R
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Nov; 28(7):1071-8. PubMed ID: 15610919
[TBL] [Abstract][Full Text] [Related]
7. Cerebral glucose metabolic response to combined total sleep deprivation and antidepressant treatment in geriatric depression.
Smith GS; Reynolds CF; Pollock B; Derbyshire S; Nofzinger E; Dew MA; Houck PR; Milko D; Meltzer CC; Kupfer DJ
Am J Psychiatry; 1999 May; 156(5):683-9. PubMed ID: 10327899
[TBL] [Abstract][Full Text] [Related]
8. A New Single-Item Sleep Quality Scale: Results of Psychometric Evaluation in Patients With Chronic Primary Insomnia and Depression.
Snyder E; Cai B; DeMuro C; Morrison MF; Ball W
J Clin Sleep Med; 2018 Nov; 14(11):1849-1857. PubMed ID: 30373688
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of suanzaoren decoction for chronic insomnia disorder in adults: study protocol for randomised, double-blind, double-dummy, placebo-controlled trial.
Zhou QH; Wang HL; Zhou XL; Xu MB; Zhang HF; Huang LB; Zheng GQ; Lin Y
BMJ Open; 2017 Apr; 7(4):e014280. PubMed ID: 28377394
[TBL] [Abstract][Full Text] [Related]
10. [Effects of paroxetine with or without zolpidem on depression with insomnia: a multi-center randomized comparative study].
Ji JL; Liu WJ; Zhang N; Chen ZQ; Zheng AL; Mei QY; Pan JY; Zhao ZX; Tao M; Wang YP; Wei J
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(23):1585-9. PubMed ID: 17803844
[TBL] [Abstract][Full Text] [Related]
11. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder.
Fava M; McCall WV; Krystal A; Wessel T; Rubens R; Caron J; Amato D; Roth T
Biol Psychiatry; 2006 Jun; 59(11):1052-60. PubMed ID: 16581036
[TBL] [Abstract][Full Text] [Related]
12. The efficacy and tolerability of once-daily controlled-release trazodone for depressed mood, anxiety, insomnia, and suicidality in major depressive disorder.
Sheehan DV; Rozova A; Gossen ER; Gibertini M
Psychopharmacol Bull; 2009; 42(4):5-22. PubMed ID: 20581790
[TBL] [Abstract][Full Text] [Related]
13. Persistent psychophysiologic insomnia: preliminary Research Diagnostic Criteria and EEG sleep data.
Reynolds CF; Taska LS; Sewitch DE; Restifo K; Coble PA; Kupfer DJ
Am J Psychiatry; 1984 Jun; 141(6):804-5. PubMed ID: 6731625
[TBL] [Abstract][Full Text] [Related]
14. Ramelteon for insomnia symptoms in a community sample of adults with generalized anxiety disorder: an open label study.
Gross PK; Nourse R; Wasser TE
J Clin Sleep Med; 2009 Feb; 5(1):28-33. PubMed ID: 19317378
[TBL] [Abstract][Full Text] [Related]
15. Redistribution of slow wave activity of sleep during pharmacological treatment of depression with paroxetine but not with nefazodone.
Argyropoulos SV; Hicks JA; Nash JR; Bell CJ; Rich AS; Nutt DJ; Wilson S
J Sleep Res; 2009 Sep; 18(3):342-8. PubMed ID: 19549078
[TBL] [Abstract][Full Text] [Related]
16. Sleep laboratory study on single and repeated dose effects of paroxetine, alprazolam and their combination in healthy young volunteers.
Barbanoj MJ; Clos S; Romero S; Morte A; Giménez S; Lorenzo JL; Luque A; Dal-Ré R
Neuropsychobiology; 2005; 51(3):134-47. PubMed ID: 15838185
[TBL] [Abstract][Full Text] [Related]
17. Should anxiety and insomnia influence antidepressant selection: a randomized comparison of fluoxetine and imipramine.
Simon GE; Heiligenstein JH; Grothaus L; Katon W; Revicki D
J Clin Psychiatry; 1998 Feb; 59(2):49-55. PubMed ID: 9501885
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of tianeptine in major depression: evidence from a 3-month controlled clinical trial versus paroxetine.
Waintraub L; Septien L; Azoulay P
CNS Drugs; 2002; 16(1):65-75. PubMed ID: 11772119
[TBL] [Abstract][Full Text] [Related]
19. Confirmation of the neurophysiologically predicted therapeutic effects of trazodone on its target symptoms depression, anxiety and insomnia by postmarketing clinical studies with a controlled-release formulation in depressed outpatients.
Saletu-Zyhlarz GM; Anderer P; Arnold O; Saletu B
Neuropsychobiology; 2003; 48(4):194-208. PubMed ID: 14673218
[TBL] [Abstract][Full Text] [Related]
20. EEG correlates of acute and chronic paroxetine treatment in depression.
Knott V; Mahoney C; Kennedy S; Evans K
J Affect Disord; 2002 May; 69(1-3):241-9. PubMed ID: 12103473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
